XML 46 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets (in thousands):
As of December 31,
20232022
Cash and cash equivalents$62,888 $39,019 
Restricted cash, non-current64 64 
Total cash, cash equivalents and restricted cash$62,952 $39,083 
Schedule of Restricted Cash and Cash Equivalents The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets (in thousands):
As of December 31,
20232022
Cash and cash equivalents$62,888 $39,019 
Restricted cash, non-current64 64 
Total cash, cash equivalents and restricted cash$62,952 $39,083 
Schedule of Inventory
Details of inventory are presented as follows (in thousands):
As of December 31,
20232022
Raw materials$4,640 $944 
Work in process1,366 — 
Finished goods421 917 
Total$6,427 $1,861 
Schedule of Property and Equipment
Details of property and equipment are presented as follows (in thousands).
As of December 31,
20232022
Computers and software$464 $338 
Furniture and fixtures65 65 
Construction in process4,389 77 
Lab equipment25 — 
Leasehold improvements129 129 
Total$5,072 $609 
Accumulated depreciation(270)(101)
Property and equipment, net$4,802 $508 
Schedule of Gross-to-Net Sales Adjustments
The following table sets forth the changes in the accrued revenue allowances (in thousands):
As of December 31,
20232022
Balance at beginning of period$1,434 $— 
Provision for current period sales4,648 2,438 
Payments(5,017)(1,004)
Balance at end of period$1,065 $1,434 
Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share
The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net loss per share because their inclusion would be anti-dilutive:
Year Ended December 31,
20232022
Options to purchase common stock4,579,659 2,990,423 
Restricted Stock Units to purchase common stock32,558 — 
Warrants to purchase common stock29,167 29,167